http://www.biomarin.com
BioMarin Pharmaceutical Inc. Company Intro
Industry
Healthcare
BioMarin Pharmaceutical Inc. Headquaters
770 Lindaro Street
San Rafael,94901
United States
BioMarin Pharmaceutical Inc. Share price
20 Oct 2020 01:14 GMT
$79.70
0.45 (0.57 %)
BioMarin Pharmaceutical Inc. Market cap
$14.024 B
WMC RANKING
2020
BioMarin Pharmaceutical Inc. # 7
BiotechnologyLatest BioMarin Pharmaceutical Inc. News
20 Oct 2020
Gaucher Disease Treatment Market boosting the growth Worldwide: Market dynamics and trends, efficiencies Forecast 2022
Pfizer Inc. Shire Human Genetic Therapies. Eli Lilly and Company. Enobia Pharma Inc. Anthera Pharmaceuticals. BioMarin Pharmaceutical. MedPro Rx.
20 Oct 2020
Technicalities drives to Growth: Ionis Pharmaceuticals Inc. (IONS), BioMarin Pharmaceutical Inc. (BMRN)
(IONS), BioMarin Pharmaceutical Inc. (BMRN). By. Melanie Gerald. -. October 20, 2020.
20 Oct 2020
Rare Disease Treatment Market Insights 2027: Analysis ...
Merck & Co., Inc. Vertex Pharmaceuticals Baxter BioMarin. Teva Pharmaceutical Industries Ltd. Others. The objective of the researchers is to find out sales, value ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| BioMarin Pharmaceutical Inc. | 28.95 | 0.67 | 43.87 | 1 | 0 | 0 | 33.22 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.32 | 100 | 20 | 0 | 0 | 96.20 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.68 | 33 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0.06 |
| Incyte Corporation | 40.27 | 8.70 | 7.11 | 100 | 0 | 0 | 84.84 |
BioMarin Pharmaceutical Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BioMarin Pharmaceutical Inc. | $1,602,819 | $1,438,676 | $-42,522 | $14.024B | 7 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.687B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $57.436B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.572B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.193B | 4 |